ClinicalTrials.govpublic full text
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
metastatic breast cancer, advanced breast cancer, breast cancer, investigational drug, drug therapy, antineoplastic protocols, immunotherapy, stage iv breast cancer, her-2/neu expressing breast cancer, her-2/neu, trastuzumab refractory, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803856
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.